Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD

0.35  0 (-0.03%)

After market: 0.352 +0 (+0.57%)

Fundamental Rating

5

Taking everything into account, MHUA scores 5 out of 10 in our fundamental rating. MHUA was compared to 190 industry peers in the Health Care Equipment & Supplies industry. MHUA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MHUA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year MHUA was profitable.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.12%, MHUA belongs to the top of the industry, outperforming 90.96% of the companies in the same industry.
With an excellent Return On Equity value of 10.93%, MHUA belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.
MHUA has a Return On Invested Capital of 8.53%. This is amongst the best in the industry. MHUA outperforms 87.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MHUA is in line with the industry average of 8.14%.
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROIC 8.53%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

The Profit Margin of MHUA (11.47%) is better than 87.77% of its industry peers.
MHUA's Profit Margin has declined in the last couple of years.
The Operating Margin of MHUA (14.44%) is better than 84.04% of its industry peers.
In the last couple of years the Operating Margin of MHUA has declined.
MHUA has a worse Gross Margin (33.97%) than 71.81% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
Industry RankSector Rank
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
Compared to 1 year ago, MHUA has about the same amount of shares outstanding.
Compared to 5 years ago, MHUA has more shares outstanding
The debt/assets ratio for MHUA is higher compared to a year ago.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

MHUA has an Altman-Z score of 3.05. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MHUA (3.05) is better than 67.02% of its industry peers.
The Debt to FCF ratio of MHUA is 1.37, which is an excellent value as it means it would take MHUA, only 1.37 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MHUA (1.37) is better than 89.89% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that MHUA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, MHUA is in line with its industry, outperforming 59.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Altman-Z 3.05
ROIC/WACC1.3
WACC6.57%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

MHUA has a Current Ratio of 4.78. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA's Current ratio of 4.78 is fine compared to the rest of the industry. MHUA outperforms 76.06% of its industry peers.
MHUA has a Quick Ratio of 4.74. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA has a better Quick ratio (4.74) than 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.74
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

MHUA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.80%, which is quite good.
The Earnings Per Share has been decreasing by -8.81% on average over the past years.
MHUA shows a decrease in Revenue. In the last year, the revenue decreased by -6.00%.
Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 5.11% on average per year.
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.95%
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MHUA Yearly EPS VS EstimatesMHUA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

MHUA is valuated cheaply with a Price/Earnings ratio of 0.55.
MHUA's Price/Earnings ratio is rather cheap when compared to the industry. MHUA is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of MHUA to the average of the S&P500 Index (30.30), we can say MHUA is valued rather cheaply.
Industry RankSector Rank
PE 0.55
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MHUA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.3
EV/EBITDA -0.35
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (2/20/2025, 8:00:00 PM)

After market: 0.352 +0 (+0.57%)

0.35

0 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners2.53%
Inst Owner Change-89.56%
Ins Owners56.48%
Ins Owner ChangeN/A
Market Cap11.16M
AnalystsN/A
Price TargetN/A
Short Float %0.79%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.55
Fwd PE N/A
P/S 0.08
P/FCF 1.3
P/OCF 1.28
P/B 0.07
P/tB 0.07
EV/EBITDA -0.35
EPS(TTM)0.64
EY182.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY76.98%
OCF(TTM)0.27
OCFY78.03%
SpS4.47
BVpS4.69
TBVpS4.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROCE 13.75%
ROIC 8.53%
ROICexc 9.64%
ROICexgc 9.67%
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
FCFM 6.03%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
ROICexc(3y)10.01%
ROICexc(5y)15.52%
ROICexgc(3y)10.12%
ROICexgc(5y)15.69%
ROCE(3y)14.05%
ROCE(5y)20.48%
ROICexcg growth 3Y-27.88%
ROICexcg growth 5Y-29.21%
ROICexc growth 3Y-28.39%
ROICexc growth 5Y-29.35%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Debt/EBITDA 0.56
Cap/Depr 24.8%
Cap/Sales 0.08%
Interest Coverage 86.22
Cash Conversion 41.41%
Profit Quality 52.59%
Current Ratio 4.78
Quick Ratio 4.74
Altman-Z 3.05
F-Score4
WACC6.57%
ROIC/WACC1.3
Cap/Depr(3y)537.8%
Cap/Depr(5y)817.44%
Cap/Sales(3y)2.75%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3Y-14.53%
EBIT growth 5Y-5.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.84%
OCF growth 3Y-24.7%
OCF growth 5Y-28.07%